Cargando…
Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
BACKGROUND: Eptifibatide is an inhibitor of the platelet glycoprotein (GP) IIb/IIIa receptor that is commonly used in patients undergoing percutaneous coronary intervention (PCI). CASE: We describe a case of a 62-year-old female patient admitted with acute ST-elevation myocardial infarction (STEMI)...
Autores principales: | Aljundi, Amer, Rahhal, Alaa, Dabdoob, Wafer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303759/ https://www.ncbi.nlm.nih.gov/pubmed/32566320 http://dx.doi.org/10.1155/2020/8386709 |
Ejemplares similares
-
Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014) -
Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010) -
Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021) -
Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022) -
A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)